梁微微;李乃适;潘慧;

• 1:中国医学科学院北京协和医学院北京协和医院内分泌科卫生部内分泌重点实验室

摘要(Abstract)：

<正>近年来,随着社会经济的发展和生活方式的改变,代谢综合征的患病率逐年上升,已成为严重危害人类身体健康的隐性杀手之一。在临床,代谢综合征有多种表现,包括肥胖、高血压、高血糖、血脂异常等[1],而胰岛素抵抗是代谢综合征诸多症状发生的中心环节[1]。但胰岛素抵抗的机制目前尚未彻底阐明。现有研究表明慢性炎症反应是导致胰岛素抵抗发生、发展的重要因素之一,而白细胞介素(interleukin,

关键词(KeyWords)： NALP3炎症体;胰岛素抵抗

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 梁微微;李乃适;潘慧;

参考文献(References)：

• [1]Eckel RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365:1415-1428.
• [2]Tschopp J,Martinon F,Burns K.NALPs:a novel protein family involved in inflammation[J].Nat Rev Mol Cell Biol,2003,4:95-104.
• [3]Fritz JH,Ferrero RL,Philpott DJ,et al.Nod-like proteins in immunity,inflammation and disease[J].Nat Immunol,2006,7:1250-1257.
• [4]Latz E,Xiao TS,Stutz A.Activation and regulation of the inflammasomes[J].Nat Rev Immunol,2013,13:397-411.
• [5]Zhou R,Tardivel A,Thorens B,et al.Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J].Nat Immunol,2010,11:136-140.
• [6]Kanneganti TD,Dixit VD.Immunological complications of obesity[J].Nat Immunol,2012,13:707-712.
• [7]Donath MY,Shoelson SE.Type 2 diabetes as an inflammatory disease[J].Nat Rev Immunol,2011,11:98-107.
• [8]Hotamisligil GS,Erbay E.Nutrient sensing and inflammation in metabolic diseases[J].Nat Rev Immunol,2008,8:923-934.
• [9]Vandanmagsar B,Youm YH,Ravussin A,et al.The NLRP3inflammasome instigates obesity-induced inflammation and insulin resistance[J].Nat Med,2011,17:179-188.
• [10]Wen H,Gris D,Lei Y,et al.Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling[J].Nat Immunol,2011,12:408-415.
• [11]Stienstra R,Joosten LAB,Koenen T,et al.The Inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity[J].Cell Metab,2010,12:593-605.
• [12]Masters SL,Dunne A,Subramanian SL,et al.Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes[J].Nat Immunol,2010,11:897-904.
• [13]Koenen TB,Stienstra R,van Tits LJ,et al.Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1 beta transcription in human adipose tissue[J].Diabetes,2011,60:517-524.
• [14]Jager J,Gremeaux T,Cormont M,et al.Interleukin-1betainduced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression[J].Endocrinology,2007,148:241-251.
• [15]Spranger J,Kroke A,Mohlig M,et al.Inflammatory cytokines and the risk to develop type 2 diabetes:results of the prospective population-based European Prospective Investigation into Cancer and Nutrition(EPIC)-Potsdam Study[J].Diabetes,2003,52:812-817.
• [16]Malozowski S,Sahlroot JT.Interleukin-1-receptor antagonist in type 2 diabetes mellitus[J].N Engl J Med,2007,357:302-303.
• [17]Akash MS,Shen Q,Rehman K,et al.Interleukin-1 receptor antagonist:a new therapy for type 2 diabetes mellitus[J].J Pharm Sci,2012,101:1647-1658.
• [18]Ridker PM,Howard CP,Walter V,et al.Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c,lipids,C-reactive protein,interleukin-6,and fibrinogen:a phase IIb randomized,placebo-controlled trial[J].Circulation,2012,126:2739-2748.
• [19]Cavelti-Weder C,Babians-Brunner A,Keller C,et al.Effects of gevokizumab on glycemia and inflammatory markers in type2 diabetes[J].Diabetes Care,2012,35:1654-1662.
• [20]Sloan-Lancaster J,Abu-Raddad E,Polzer J,et al.Doubleblind,randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102,a neutralizing IL-1beta antibody,in patients with type 2 diabetes[J].Diabetes Care,2013,36:2239-2246.
• [21]Rotter V,Nagaev I,Smith U.Interleukin-6(IL-6)inducesinsulin resistance in 3T3-L1 adipocytes and is,like IL-8 and tumor necrosis factor-alpha,overexpressed in human fat cells from insulin-resistant subjects[J].J Biol Chem,2003,278:45777-45784.
• [22]Senn JJ,Klover PJ,Nowak IA,et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51:3391-3399.
• [23]Senn JJ,Klover PJ,Nowak IA,et al.Suppressor of cytokine signaling-3(SOCS-3),a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes[J].J Biol Chem,2003,278:13740-13746.
• [24]Bastard JP,Jardel C,Bruckert E,et al.Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss[J].J Clin Endocrinol Metab,2000,85:3338-3342.
• [25]Wang X,Bao W,Liu J,et al.Inflammatory markers and risk of type 2 diabetes:a systematic review and meta-analysis[J].Diabetes Care,2013,36:166-175.
• [26]Hotamisligil GS,Budavari A,Murray D,et al.Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes.Central role of tumor necrosis factor-alpha[J].J Clin Invest,1994,94:1543-1549.
• [27]Kern PA,Saghizadeh M,Ong JM,et al.The expression of tumor necrosis factor in human adipose tissue.Regulation by obesity,weight loss,and relationship to lipoprotein lipase[J].J Clin Invest,1995,95:2111-2119.
• [28]Ziccardi P,Nappo F,Giugliano G,et al.Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year[J].Circulation,2002,105:804-809.
• [29]Hivert MF,Sullivan LM,Fox CS,et al.Associations of adiponectin,resistin,and tumor necrosis factor-alpha with insulin resistance[J].J Clin Endocrinol Metab,2008,93:3165-3172.
• [30]Lumeng CN,Bodzin JL,Saltiel AR.Obesity induces a phenotypic switch in adipose tissue macrophage polarization[J].J Clin Invest,2007,117:175-184.
• [31]Lee HM,Kim JJ,Kim HJ,et al.Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes[J].Diabetes,2013,62:194-204.
• [32]Zheng Y,Zhang D,Zhang L,et al.Variants of NLRP3 gene are associated with insulin resistance in Chinese Han population with type-2 diabetes[J].Gene,2013,530:151-154.
• [33]Dehghan A,Dupuis J,Barbalic M,et al.Meta-analysis of genome-wide association studies in>80 000 subjects identifies multiple loci for C-reactive protein levels[J].Circulation,2011,123:731-738.
• [34]Lamkanfi M,Mueller JL,Vitari AC,et al.Glyburide inhibits the Cryopyrin/Nalp3 inflammasome[J].J Cell Biol,2009,187:61-70.